Block on Trump's Asylum Ban Upheld by Supreme Court
In a products liability action concerning an allegedly defective hormone replacement drug, the district court's orders denying plaintiffs' motion to remand and dismissing duplicative actions are reversed where the plaintiffs' alleged misjoinder to defeat diversity jurisdiction was not so egregious as to constitute fraudulent misjoinder.
Submitted: September 24, 2009
Filed: January 6, 2010
Opinion by Judge Bright